You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CEFEPIME HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for cefepime hydrochloride and what is the scope of freedom to operate?

Cefepime hydrochloride is the generic ingredient in six branded drugs marketed by B Braun, Acs Dobfar, Astral, Chartwell Rx, Hikma, Hospira Inc, Qilu, Sagent Pharms Inc, Baxter Hlthcare, Samson Medcl, and Allecra Theraps, and is included in thirteen NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for cefepime hydrochloride. Nine suppliers are listed for this compound.

Summary for CEFEPIME HYDROCHLORIDE
US Patents:2
Tradenames:6
Applicants:11
NDAs:13
Drug Master File Entries: 9
Finished Product Suppliers / Packagers: 9
Raw Ingredient (Bulk) Api Vendors: 114
Clinical Trials: 61
Patent Applications: 761
What excipients (inactive ingredients) are in CEFEPIME HYDROCHLORIDE?CEFEPIME HYDROCHLORIDE excipients list
DailyMed Link:CEFEPIME HYDROCHLORIDE at DailyMed
Recent Clinical Trials for CEFEPIME HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Biomedical Advanced Research and Development AuthorityPhase 3
Meiji Seika Pharma Co., Ltd.Phase 3
AllecraPhase 2

See all CEFEPIME HYDROCHLORIDE clinical trials

Pharmacology for CEFEPIME HYDROCHLORIDE

US Patents and Regulatory Information for CEFEPIME HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 214402-002 May 22, 2024 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Allecra Theraps EXBLIFEP cefepime hydrochloride; enmetazobactam POWDER;INTRAVENOUS 216165-001 Feb 22, 2024 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Allecra Theraps EXBLIFEP cefepime hydrochloride; enmetazobactam POWDER;INTRAVENOUS 216165-001 Feb 22, 2024 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Samson Medcl CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER cefepime hydrochloride POWDER;INTRAVENOUS 209408-001 Aug 21, 2018 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Qilu CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 203704-002 Feb 1, 2016 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Qilu CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 203704-003 Feb 1, 2016 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Acs Dobfar CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 065441-002 Mar 20, 2008 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.